{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:44:00Z","timestamp":1759938240987},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T00:00:00Z","timestamp":1190073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T00:00:00Z","timestamp":1190073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00262-007-0388-y","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T12:37:27Z","timestamp":1190032647000},"page":"493-505","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma"],"prefix":"10.1007","volume":"57","author":[{"given":"Paul","family":"Neeson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen Kun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,18]]},"reference":[{"key":"388_CR1","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","volume":"92","author":"FD Groves","year":"2000","unstructured":"Groves FD, Linet MS, Travis LB, Devesa SS (2000) Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 92:1240\u20131251","journal-title":"J Natl Cancer Inst"},{"key":"388_CR2","unstructured":"Ries LAG, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2006) SEER Cancer Statistics Review, 1975\u20132003. National Cancer Institute. Bethesda"},{"key":"388_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","volume":"105","author":"R Marcus","year":"2005","unstructured":"Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J, Solal-Celigny P, Offner F, Walewski J, Raposo J, Jack A, Smith P (2005) CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 105:1417\u20131423","journal-title":"Blood"},{"key":"388_CR4","first-page":"1183","volume":"2","author":"AR Jazirehi","year":"2003","unstructured":"Jazirehi AR, Gan XH, De Vos S, Emmanouilides C, Bonavida B (2003) Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin\u2019s lymphoma B cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 2:1183\u20131193","journal-title":"Mol Cancer Ther"},{"key":"388_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1182\/blood-2002-02-0469","volume":"101","author":"O Manches","year":"2003","unstructured":"Manches O, Lui G, Chaperot L, Gressin R, Molens JP, Jacob MC, Sotto JJ, Leroux D, Bensa JC, Plumas J (2003) In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood 101:949\u2013954","journal-title":"Blood"},{"key":"388_CR6","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1200\/JCO.2003.05.013","volume":"21","author":"WK Weng","year":"2003","unstructured":"Weng WK, Levy R (2003) Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 21:3940\u20133947","journal-title":"J Clin Oncol"},{"key":"388_CR7","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.onc.1208349","volume":"24","author":"AR Jazirehi","year":"2005","unstructured":"Jazirehi AR, Bonavida B (2005) Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin\u2019s lymphoma: implications in chemosensitization and therapeutic intervention. Oncogene 24:2121\u20132143","journal-title":"Oncogene"},{"key":"388_CR8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.264.65.1","volume":"65","author":"AR Jazirehi","year":"2005","unstructured":"Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B (2005) Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin\u2019s lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer Res 65:264\u2013276","journal-title":"Cancer Res"},{"key":"388_CR9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4049\/jimmunol.177.1.362","volume":"177","author":"JL Teeling","year":"2006","unstructured":"Teeling JL, Mackus WJ, Wiegman LJ, van den Brakel JH, Beers SA, French RR, van Meerten T, Ebeling S, Vink T, Slootstra JW, Parren PW, Glennie MJ, van de Winkel JG (2006) The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20. J Immunol 177:362\u2013371","journal-title":"J Immunol"},{"key":"388_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1586\/14760584.5.3.381","volume":"5","author":"SS Neelapu","year":"2006","unstructured":"Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW (2006) Therapeutic lymphoma vaccines: importance of T-cell immunity. Expert Rev Vaccines 5:381\u2013394","journal-title":"Expert Rev Vaccines"},{"key":"388_CR11","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4049\/jimmunol.137.9.3019","volume":"137","author":"TY Basham","year":"1986","unstructured":"Basham TY, Kaminski MS, Kitamura K, Levy R, Merigan TC (1986) Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma. J Immunol 137:3019\u20133024","journal-title":"J Immunol"},{"key":"388_CR12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4049\/jimmunol.136.3.1123","volume":"136","author":"MS Kaminski","year":"1986","unstructured":"Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R (1986) Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol 136:1123\u20131130","journal-title":"J Immunol"},{"key":"388_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V69.1.199.199","volume":"69","author":"JN Lowder","year":"1987","unstructured":"Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R (1987) Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. Blood 69:199\u2013210","journal-title":"Blood"},{"key":"388_CR14","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood.V80.6.1502.1502","volume":"80","author":"DG Maloney","year":"1992","unstructured":"Maloney DG, Brown S, Czerwinski DK, Liles TM, Hart SM, Miller RA, Levy R (1992) Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells. Blood 80:1502\u20131510","journal-title":"Blood"},{"key":"388_CR15","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V92.4.1184","volume":"92","author":"TA Davis","year":"1998","unstructured":"Davis TA, Maloney DG, Czerwinski DK, Liles TM, Levy R (1998) Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin\u2019s lymphoma without eradicating the malignant clone. Blood 92:1184\u20131190","journal-title":"Blood"},{"key":"388_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1749-6632.1993.tb44039.x","volume":"690","author":"FJ Hsu","year":"1993","unstructured":"Hsu FJ, Kwak L, Campbell M, Liles T, Czerwinski D, Hart S, Syrengelas A, Miller R, Levy R (1993) Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann N Y Acad Sci 690:385\u2013387","journal-title":"Ann N Y Acad Sci"},{"key":"388_CR17","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","volume":"89","author":"FJ Hsu","year":"1997","unstructured":"Hsu FJ, Caspar CB, Czerwinski D, Kwak LW, Liles TM, Syrengelas A, Taidi-Laskowski B, Levy R (1997) Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma\u2013long-term results of a clinical trial. Blood 89:3129\u20133135","journal-title":"Blood"},{"key":"388_CR18","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1200\/JCO.2005.04.4289","volume":"24","author":"CH Redfern","year":"2006","unstructured":"Redfern CH, Guthrie TH, Bessudo A, Densmore JJ, Holman PR, Janakiraman N, Leonard JP, Levy RL, Just RG, Smith MR, Rosenfelt FP, Wiernik PH, Carter WD, Gold DP, Melink TJ, Gutheil JC, Bender JF (2006) Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin\u2019s lymphoma resulting in durable clinical responses. J Clin Oncol 24:3107\u20133112","journal-title":"J Clin Oncol"},{"key":"388_CR19","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood.V90.9.3699","volume":"90","author":"CB Caspar","year":"1997","unstructured":"Caspar CB, Levy S, Levy R (1997) Idiotype vaccines for non-Hodgkin\u2019s lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations. Blood 90:3699\u20133706","journal-title":"Blood"},{"key":"388_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJM199210223271705","volume":"327","author":"LW Kwak","year":"1992","unstructured":"Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327:1209\u20131215","journal-title":"N Engl J Med"},{"key":"388_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/13928","volume":"5","author":"M Bendandi","year":"1999","unstructured":"Bendandi M, Gocke CD, Kobrin CB, Benko FA, Sternas LA, Pennington R, Watson TM, Reynolds CW, Gause BL, Duffey PL, Jaffe ES, Creekmore SP, Longo DL, Kwak LW (1999) Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 5:1171\u20131177","journal-title":"Nat Med"},{"key":"388_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1517\/14712598.5.6.841","volume":"5","author":"SA Hurvitz","year":"2005","unstructured":"Hurvitz SA, Timmerman JM (2005) Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin\u2019s lymphomas: a focus on FavId. Expert Opin Biol Ther 5:841\u2013852","journal-title":"Expert Opin Biol Ther"},{"key":"388_CR23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.145.3.1029","volume":"145","author":"MJ Campbell","year":"1990","unstructured":"Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R (1990) Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol 145:1029\u20131036","journal-title":"J Immunol"},{"key":"388_CR24","first-page":"323","volume":"15","author":"LW Kwak","year":"1991","unstructured":"Kwak LW, Campbell M, Levy R (1991) Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model. Cancer Detect Prev 15:323\u2013325","journal-title":"Cancer Detect Prev"},{"key":"388_CR25","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.4049\/jimmunol.155.11.5227","volume":"155","author":"MS Villanueva","year":"1995","unstructured":"Villanueva MS, Sijts AJ, Pamer EG (1995) Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenes-infected cells. J Immunol 155:5227\u20135233","journal-title":"J Immunol"},{"key":"388_CR26","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.4049\/jimmunol.158.7.3366","volume":"158","author":"S Vijh","year":"1997","unstructured":"Vijh S, Pamer EG (1997) Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J Immunol 158:3366\u20133371","journal-title":"J Immunol"},{"key":"388_CR27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/IAI.67.3.1303-1309.1999","volume":"67","author":"S Vijh","year":"1999","unstructured":"Vijh S, Pilip IM, Pamer EG (1999) Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection. Infect Immun 67:1303\u20131309","journal-title":"Infect Immun"},{"key":"388_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mib.2003.12.002","volume":"7","author":"M Lara-Tejero","year":"2004","unstructured":"Lara-Tejero M, Pamer EG (2004) T cell responses to Listeria monocytogenes. Curr Opin Microbiol 7:45\u201350","journal-title":"Curr Opin Microbiol"},{"key":"388_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nri1461","volume":"4","author":"EG Pamer","year":"2004","unstructured":"Pamer EG (2004) Immune responses to Listeria monocytogenes. Nat Rev Immunol 4:812\u2013823","journal-title":"Nat Rev Immunol"},{"key":"388_CR30","first-page":"454","volume":"7","author":"Y Paterson","year":"2005","unstructured":"Paterson Y, Maciag PC (2005) Listeria-based vaccines for cancer treatment. Curr Opin Mol Ther 7:454\u2013460","journal-title":"Curr Opin Mol Ther"},{"key":"388_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00262-006-0240-9","volume":"56","author":"X Peng","year":"2006","unstructured":"Peng X, Treml J, Paterson Y (2006) Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy. Cancer Immunol Immunother 56:797\u2013806","journal-title":"Cancer Immunol Immunother"},{"key":"388_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/eji.1830070702","volume":"7","author":"Y Bergman","year":"1977","unstructured":"Bergman Y, Haimovich J (1977) Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H\/eB origin. Eur J Immunol 7:413\u2013417","journal-title":"Eur J Immunol"},{"key":"388_CR33","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/eji.1830070815","volume":"7","author":"Y Bergman","year":"1977","unstructured":"Bergman Y, Haimovich J, Melchers F (1977) An IgM-producing tumor with biochemical characteristics of a small B lymphocyte. Eur J Immunol 7:574\u2013579","journal-title":"Eur J Immunol"},{"key":"388_CR34","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1084\/jem.168.5.1607","volume":"168","author":"WL Carroll","year":"1988","unstructured":"Carroll WL, Starnes CO, Levy R, Levy S (1988) Alternative V kappa gene rearrangements in a murine B cell lymphoma. An explantation for idiotypic heterogeneity. J Exp Med 168:1607\u20131620","journal-title":"J Exp Med"},{"key":"388_CR35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4049\/jimmunol.141.1.333","volume":"141","author":"CO Starnes","year":"1988","unstructured":"Starnes CO, Carroll WL, Campbell MJ, Houston LL, Apell G, Levy R (1988) Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants. J Immunol 141:333\u2013339","journal-title":"J Immunol"},{"key":"388_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/hyb.1985.4.191","volume":"4","author":"DG Maloney","year":"1985","unstructured":"Maloney DG, Kaminski MS, Burowski D, Haimovich J, Levy R (1985) Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4:191\u2013209","journal-title":"Hybridoma"},{"key":"388_CR37","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.4049\/jimmunol.122.6.2430","volume":"122","author":"Z Eshhar","year":"1979","unstructured":"Eshhar Z, Blatt C, Bergman Y, Heimovich J (1979) Induction of secretion of IgM from cells of the B cell line 38c-13 by somatic cell hybridization. J Immunol 122:2430\u20132434","journal-title":"J Immunol"},{"key":"388_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0022-1759(99)00122-2","volume":"230","author":"M Trebak","year":"1999","unstructured":"Trebak M, Chong JM, Herlyn D, Speicher DW (1999) Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. J Immunol Methods 230:59\u201370","journal-title":"J Immunol Methods"},{"key":"388_CR39","unstructured":"Andrew SM, Titus JA (1997) Purification of IgM. In: Kruisbeek A, Coligan J, Marguiles D, Shevach E, Strober W (eds) Current protcols in immunology, Unit 2.9"},{"key":"388_CR40","unstructured":"Andrew SM, Titus JA (1997) Purification of IgG. Alternate protocol 1: affinity chromatography using protein G sepharose. In: Kruisbeek A, Coligan J, Marguiles D, Shevach E, Strober W (eds) Current protcols in immunology, Unit 2.7"},{"key":"388_CR41","unstructured":"Holmes K, Lants L, Fowlkes B, Schmid I, Giorgi J (2003) Support protocol 1: labeling antibody with Fluorescein Isothiocyanate (FITC). In: Kruisbeek A, Coligan J, Marguiles D, Shevach E, Strober W (eds) Current protocols in immunology, Unit 5.3. Wiley, New York"},{"key":"388_CR42","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1083\/jcb.200201081","volume":"156","author":"IJ Glomski","year":"2002","unstructured":"Glomski IJ, Gedde MM, Tsang AW, Swanson JA, Portnoy DA (2002) The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. J Cell Biol 156:1029\u20131038","journal-title":"J Cell Biol"},{"key":"388_CR43","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1128\/iai.59.12.4641-4646.1991","volume":"59","author":"F Nato","year":"1991","unstructured":"Nato F, Reich K, Lhopital S, Rouyre S, Geoffroy C, Mazie JC, Cossart P (1991) Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O. Infect Immun 59:4641\u20134646","journal-title":"Infect Immun"},{"key":"388_CR44","unstructured":"Biragyn A, Kwak L (2006) Models for lymphoma. In: BB, Coligan J, Marguilies D, Shevach E, Strober W, Brown P, Donovan J (eds) Unit 20.26. Wiley, New York"},{"key":"388_CR45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/iai.1.4.363-372.1970","volume":"1","author":"GC Kingdon","year":"1970","unstructured":"Kingdon GC, Sword CP (1970) Biochemical and immunological effects of Listeria monocytogenes Hemolysin. Infect Immun 1:363\u2013372","journal-title":"Infect Immun"},{"key":"388_CR46","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1084\/jem.167.4.1459","volume":"167","author":"DA Portnoy","year":"1988","unstructured":"Portnoy DA, Jacks PS, Hinrichs DJ (1988) Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 167:1459\u20131471","journal-title":"J Exp Med"},{"key":"388_CR47","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1084\/jem.166.5.1484","volume":"166","author":"MD Witmer-Pack","year":"1987","unstructured":"Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM (1987) Granulocyte\/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484\u20131498","journal-title":"J Exp Med"},{"key":"388_CR48","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1084\/jem.167.2.700","volume":"167","author":"C Heufler","year":"1988","unstructured":"Heufler C, Koch F, Schuler G (1988) Granulocyte\/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700\u2013705","journal-title":"J Exp Med"},{"key":"388_CR49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood.V88.1.202.202","volume":"88","author":"ML Disis","year":"1996","unstructured":"Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S, Cheever MA (1996) Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 88:202\u2013210","journal-title":"Blood"},{"key":"388_CR50","doi-asserted-by":"publisher","first-page":"10972","DOI":"10.1073\/pnas.93.20.10972","volume":"93","author":"LW Kwak","year":"1996","unstructured":"Kwak LW, Young HA, Pennington RW, Weeks SD (1996) Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte\/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci USA 93:10972\u201310977","journal-title":"Proc Natl Acad Sci USA"},{"key":"388_CR51","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/CDLI.7.6.859-864.2000","volume":"7","author":"N Bercovici","year":"2000","unstructured":"Bercovici N, Duffour MT, Agrawal S, Salcedo M, Abastado JP (2000) New methods for assessing T-cell responses. Clin Diagn Lab Immunol 7:859\u2013864","journal-title":"Clin Diagn Lab Immunol"},{"key":"388_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1081\/IMM-120038079","volume":"33","author":"Y Tanaka","year":"2004","unstructured":"Tanaka Y, Ohdan H, Onoe T, Asahara T (2004) Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol Invest 33:309\u2013324","journal-title":"Immunol Invest"},{"key":"388_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cyto.a.20023","volume":"60","author":"P Neeson","year":"2004","unstructured":"Neeson P, Paterson Y (2004) A new multi-parameter flow cytometric assay for monitoring lymphoma growth and spread in a pre-clinical murine model for human lymphoma. Cytometry A 60:8\u201320","journal-title":"Cytometry A"},{"key":"388_CR54","first-page":"13","volume":"35","author":"HJ Winn","year":"1972","unstructured":"Winn HJ (1972) In vivo methods for the assessment of antibody-mediated tumor immunity. Natl Cancer Inst Monogr 35:13\u201318","journal-title":"Natl Cancer Inst Monogr"},{"key":"388_CR55","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood.V78.10.2768.2768","volume":"78","author":"LW Kwak","year":"1991","unstructured":"Kwak LW, Campbell MJ, Zelenetz AD, Levy R (1991) Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy. Blood 78:2768\u20132772","journal-title":"Blood"},{"key":"388_CR56","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.4049\/jimmunol.162.8.4790","volume":"162","author":"AD Syrengelas","year":"1999","unstructured":"Syrengelas AD, Levy R (1999) DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection. J Immunol 162:4790\u20134795","journal-title":"J Immunol"},{"key":"388_CR57","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.4049\/jimmunol.164.9.4797","volume":"164","author":"JM Timmerman","year":"2000","unstructured":"Timmerman JM, Levy R (2000) Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine. J Immunol 164:4797\u20134803","journal-title":"J Immunol"},{"key":"388_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jim.2006.02.013","volume":"312","author":"SC Cha","year":"2006","unstructured":"Cha SC, Kwak LW, Ruffini PA, Qin H, Neelapu S, Biragyn A (2006) Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera. J Immunol Methods 312:79\u201393","journal-title":"J Immunol Methods"},{"key":"388_CR59","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V76.11.2411.2411","volume":"76","author":"LW Kwak","year":"1990","unstructured":"Kwak LW, Campbell MJ, Zelenetz AD, Levy R (1990) Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin. Blood 76:2411\u20132417","journal-title":"Blood"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-007-0388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-007-0388-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-007-0388-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-007-0388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:20:23Z","timestamp":1684858823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-007-0388-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,18]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1007\/s00262-007-0388-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,18]]},"assertion":[{"value":"20 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}